Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Assenat

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Radiology|February 27, 2016
Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric AnalysesStephanie Nougaret, Hebert Alberto Vargas, Yulia Lakhman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2014
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factorsChristophe Carenco, Stéphanie Faure, Astrid Herrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2025
Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX TrialEric Assenat, Meher Ben Abdelghani, Sophie Gourgou, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2025
Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX TrialEric Assenat, Meher Ben Abdelghani, Sophie Gourgou, et al.
Cancers|October 13, 2021
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaMarie Cantaloube, Florence Castan, Morgane Creoff, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patientsEmmanuelle Samalin, Thibault Mazard, Eric Assenat, et al.
The Oncologist|June 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO studyJean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier, et al.
Hepatology Communications|August 6, 2022
Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocationCecilia Gozzo, Margaux Hermida, Astrid Herrero, et al.
Molecular Cancer Therapeutics|August 21, 2013
Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pumpThibault Mazard, Annick Causse, Joelle Simony, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Radiology|February 27, 2016
Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric AnalysesStephanie Nougaret, Hebert Alberto Vargas, Yulia Lakhman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2014
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factorsChristophe Carenco, Stéphanie Faure, Astrid Herrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2025
Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX TrialEric Assenat, Meher Ben Abdelghani, Sophie Gourgou, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2025
Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX TrialEric Assenat, Meher Ben Abdelghani, Sophie Gourgou, et al.
Cancers|October 13, 2021
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular CarcinomaMarie Cantaloube, Florence Castan, Morgane Creoff, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patientsEmmanuelle Samalin, Thibault Mazard, Eric Assenat, et al.
The Oncologist|June 21, 2025
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO studyJean-Frédéric Blanc, Mohamed Bouattour, Ludovic Gauthier, et al.
Hepatology Communications|August 6, 2022
Non-transplantable recurrence after percutaneous thermal ablation of ≤3-cm HCC: Predictors and implications for treatment allocationCecilia Gozzo, Margaux Hermida, Astrid Herrero, et al.
Molecular Cancer Therapeutics|August 21, 2013
Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pumpThibault Mazard, Annick Causse, Joelle Simony, et al.
Pageof 16